"REAL-WORLD" USE OF MAVACAMTEN USE FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN AN ACADEMIC CENTER

被引：0
|
作者：
Chandrasekhar, Sanjay Amrith
Cornelio, Cyrille
Miranda, Aimon Chantara
Wu, Robby
机构：
[1] Univ S Florida, Tampa, FL USA
[2] Tampa Gen Hosp, Tampa, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1444-135
引用
收藏
页码：680 / 680
页数：1
相关论文
共 50 条
  • [21] Mavacamten for Obstructive Hypertrophic Cardiomyopathy in China
    Desai, Milind Y.
    JAMA CARDIOLOGY, 2023, 8 (10) : 966 - 967
  • [22] Mavacamten (Camzyos) for Obstructive Hypertrophic Cardiomyopathy
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1652): : 89 - 91
  • [23] Real-World Impact of Mavacamten on Diastolic Function in Hypertrophic Cardiomyopathy: Insights Beyond Gradient Reduction
    Rao, Roopa A.
    Das, Mithilesh K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 242 : 95 - 96
  • [24] Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Rader, Florian
    Oreziak, Artur
    Choudhury, Lubna
    Saberi, Sara
    Fermin, David
    Wheeler, Matthew T.
    Abraham, Theodore P.
    Garcia-Pavia, Pablo
    Zwas, Donna R.
    Masri, Ahmad
    Owens, Anjali
    Hegde, Sheila M.
    Seidler, Tim
    Fox, Shawna
    Balaratnam, Ganesh
    Sehnert, Amy J.
    Olivotto, Iacopo
    JACC-HEART FAILURE, 2024, 12 (01) : 164 - 177
  • [25] Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension
    Wang, Andrew
    Spertus, John A.
    Wojdyla, Daniel M.
    Abraham, Theodore P.
    Nilles, Ester Kim
    Owens, Anjali Tiku
    Saberi, Sara
    Cresci, Sharon
    Sehnert, Amy
    Lakdawala, Neal K.
    JACC-HEART FAILURE, 2024, 12 (03) : 567 - 579
  • [26] Real-world use-Isavuconazole at a large academic medical center
    Hassouna, Habiba
    Athans, Vasilios
    Brizendine, Kyle D.
    MYCOSES, 2019, 62 (06) : 534 - 541
  • [27] Initial Experience With Mavacamten At A Hypertrophic Cardiomyopathy Center
    Daniel, Blen
    Afzal, Aasim
    Kabra, Nitin
    Farid, Azadeh
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [28] Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy
    Giudicessi, John R.
    Alsidawi, Said
    Geske, Jeffrey B.
    Newman, Darrell B.
    Arruda-Olson, Adelaide M.
    Bos, j. Martijn
    Ommen, Steve R.
    Ackerman, Michael J.
    MAYO CLINIC PROCEEDINGS, 2024, 99 (02) : 341 - 343
  • [29] Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy
    Zampieri, Mattia
    Argiro, Alessia
    Marchi, Alberto
    Berteotti, Martina
    Targetti, Mattia
    Fornaro, Alessandra
    Tomberli, Alessia
    Stefano, Pierluigi
    Marchionni, Niccolo
    Olivotto, Iacopo
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
  • [30] Real-world Long-term Effectiveness of Mavacamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: a Multicenter Observational Study (MARVEL-HCM)
    Abraham, Theodore
    Alsidawi, Said
    Martinez, Matthew
    Wheeler, Matthew
    Roehl, Kaitlin
    Patel, Ruchi
    Soutar, Marybeth
    Herry, Morgane
    Wang, Manchen Annie
    Kim, Mi-Ok
    Schuler, Patricia
    Dubey, Anand
    CIRCULATION, 2024, 150
12345